300452 山河药辅
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.66220.33719.18614.56916.910
总资产报酬率 ROA (%)3.22811.86312.1989.57910.981
投入资产回报率 ROIC (%)3.79214.57515.53912.19213.450

边际利润分析
销售毛利率 (%)33.34431.69129.77528.89230.956
营业利润率 (%)24.05422.09619.34316.16820.512
息税前利润/营业总收入 (%)25.24322.50019.04015.84320.449
净利润/营业总收入 (%)21.25419.61518.58513.87017.606

收益指标分析
经营活动净收益/利润总额(%)83.96682.96587.20195.11689.474
价值变动净收益/利润总额(%)11.20810.2533.7458.0943.915
营业外收支净额/利润总额(%)0.1310.2020.092-3.131-1.671

偿债能力分析
流动比率 (X)3.8973.4361.8292.4762.256
速动比率 (X)3.5963.0921.5642.1282.031
资产负债率 (%)37.57339.37633.19926.66427.273
带息债务/全部投入资本 (%)29.43229.58516.44811.598--
股东权益/带息债务 (%)228.079225.877477.156724.440657.660
股东权益/负债合计 (%)154.098142.576184.348249.352238.183
利息保障倍数 (X)21.80562.698-59.22695.53874.761

营运能力分析
应收账款周转天数 (天)41.78228.71728.02629.5810.000
存货周转天数 (天)47.50858.18061.47351.9760.000